⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 30, 2024Anticancer Research

Clinicopathological Review of Head and Neck Squamous Cell Carcinomas After Neoadjuvant Chemotherapy

Ryosuke Kuga Kazuki Hashimoto Hidetaka Yamamoto Midori Taniguchi Tomomi Manako Masanobu Sato Ryunosuke Kogo Mioko Matsuo Yoshinao Oda Takashi Nakagawa

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

The benefit of neoadjuvant chemotherapy (NAC) in the treatment of head and neck squamous cell carcinoma (HNSCC) remains unclear.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kuga et al. (2024) studied this question.

synapsesocial.com/papers/68e5639ae2b3180350f00b89 https://doi.org/10.21873/anticanres.17289

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Surgical Considerations for Head and Neck Squamous Cell Cancer Patients after Neoadjuvant ChemotherapyLiterature Review · 2026
2Neoadjuvant chemoimmunotherapy in patients with locally advanced squamous head and neck cancer: A retrospective study2025 · 6 citations
3Neoadjuvant immunotherapy in squamous cell carcinoma of the head and neck: current evidence and future perspectives2025
4Real-world evidence on definitive chemoradiotherapy following neoadjuvant chemoimmunotherapy in locally advanced head and neck squamous cell carcinoma.Randomized Controlled Trial · 2026
5Comparative efficacy and safety of neoadjuvant immunotherapy vs chemotherapy in resectable head and neck squamous cell carcinoma: an umbrella review of randomized controlled trials and single-arm studiesRCT · 2025 · 3 citations

Pathologic Response After Neoadjuvant Chemoimmunotherapy in Head and Neck Squamous Cell Carcinoma2026
Neoadjuvant chemoimmunotherapy in resectable locally advanced oral squamous cell carcinoma: a single-center retrospective cohort study2024
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for locally advanced head and neck squamous cell carcinoma2024
High Ubiquitin-like Protein 3 Expression Is Associated With Prolonged Recurrence-free Survival in Non-muscle-invasive Bladder CancerAnticancer Research · 2026
Distinct Clinical Pathways of Recurrent Cholangitis After Pancreaticoduodenectomy: Association With Hepaticojejunostomy Stricture and Early-onset CholangitisAnticancer Research · 2026

More from Anticancer Research

More from Kyushu University

More from Okayama University